Objective: Antidepressants including selective serotonin reuptake inhibitor (SSRI)-associated mania or hypomania has been well documented in the literature but these patients with switch have either mood disorders or various risk factors for bipolar disorder. This case report examines SSRI-induced hypomania in a patient with dissociative disorder and highlights hypomania as a genuine side-effect of sertraline rather than a switch.
Method: A 23-year-old female patient with dissociative disorder has been described.
Results: Hypomanic symptoms emerged during treatment with sertraline at the dose of 50 mg/day after 3-4 days of initiation of therapy and had complete recovery within 7 days after stopping sertraline.
Conclusion: In the absence of risk factors for manic switch, sertraline-induced hypomania may be a true side-effect of drug.
QuickSearch in:
Key words:
Accepted for publication December 16, 2002
Affiliations
Department of Psychiatry, G.B. Pant Hospital, New Delhi, India
Correspondence
Blackwell Synergy® is a Blackwell Publishing, Inc. registered trademarkMore information about Blackwell Synergy - online journals from http://www.blackwellpublishing.com/.We welcome your Feedback. See our Privacy Statement and Terms and Conditions.Technology Partner - Atypon Systems, Inc.